BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7970467)

  • 1. Quality assessment and assurance programs in the Gynecologic Oncology Group.
    Stehman FB; Blessing JA; Fowler WC; Park RC
    Obstet Gynecol; 1994 Dec; 84(6):1059-62. PubMed ID: 7970467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gynecologic Oncology Group quality assurance audits: analysis and initiatives for improvement.
    Blessing JA; Bialy SA; Whitney CW; Stonebraker BL; Stehman FB
    Clin Trials; 2010 Aug; 7(4):390-9. PubMed ID: 20576671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgeons: A Future Role in Clinical Trials?
    Rusch VW
    Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infrastructure of cancer clinical trial cooperative groups in western countries].
    Fukuda H
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1144-51. PubMed ID: 10945009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance programs in clinical trials.
    Glicksman AS; Reinstein LE; Brotman R; McShan D
    Cancer Treat Rep; 1980; 64(2-3):425-33. PubMed ID: 7407780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved surgeon performance in clinical trials: an analysis of quality assurance audits from the American College of Surgeons Oncology Group.
    You YN; Jacobs L; Martinez ED; Budinger SC; Wittlief EJ; Myles SK; Ota DM;
    J Am Coll Surg; 2006 Sep; 203(3):269-76. PubMed ID: 16931297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Society of Gynecologic Oncology meeting highlights progress.
    Jenks S
    J Natl Cancer Inst; 2011 Apr; 103(7):533-4. PubMed ID: 21436060
    [No Abstract]   [Full Text] [Related]  

  • 9. Adapting clinical trials networks to promote cancer prevention and control research.
    Weiner BJ; McKinney MM; Carpenter WR
    Cancer; 2006 Jan; 106(1):180-7. PubMed ID: 16333855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of cancer cooperative groups in Japan.
    Fukuda H
    Jpn J Clin Oncol; 2010 Sep; 40(9):881-90. PubMed ID: 20670961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
    Zon R; Meropol NJ; Catalano RB; Schilsky RL
    J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A needs assessment of oncology nurses' perceptions of National Cancer Institute-supported clinical trial networks.
    O'Mara A; Bauer-Wu S; Berry D; Lillington L
    Oncol Nurs Forum; 2007 Mar; 34(2):E23-7. PubMed ID: 17573293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gynecologic Oncology Group (GOG).
    Gallup DG; Cella DF
    J Natl Cancer Inst Monogr; 1996; (20):77-8. PubMed ID: 8750471
    [No Abstract]   [Full Text] [Related]  

  • 14. Organizations and structures that facilitate community research.
    Coltman CA
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):107-11. PubMed ID: 8091235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality assurance issues in conducting multi-institutional advanced technology clinical trials.
    Purdy JA
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S66-70. PubMed ID: 18406941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The history of the Gynecologic Cancer Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG).
    Onda T; Konishi I; Yoshikawa H; Kamura T
    Jpn J Clin Oncol; 2011 Oct; 41(10):1156-61. PubMed ID: 21890655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mentoring of research associates in the Southwest Oncology Group (SWOG)--quality assurance in clinical trials.
    Davis B
    J Oncol Manag; 2003; 12(2):30-1. PubMed ID: 12699114
    [No Abstract]   [Full Text] [Related]  

  • 19. Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience.
    Soran A; Nesbitt L; Mamounas EP; Lembersky B; Bryant J; Anderson S; Brown A; Passarello M
    Clin Trials; 2006; 3(5):478-85. PubMed ID: 17060221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
    Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
    J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.